Isabel Vercauteren

Isabel Vercauteren serves as CEO at Aphea.Bio. Aphea.Bio operates in the research sector with approximately 81.0 employees. The company is headquartered in Ghent, Flanders. Aphea.Bio generates annual revenue of 9000000.0. To date, Aphea.Bio has raised 103703961.0 in total funding, with the most recent round being Series C.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 890 executive contacts are available in Flanders.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Outlook Microsoft Office 365 CloudFlare Hosting Google Tag Manager Mobile Friendly

microbiology agriculture research & development biologicals biocontrol biostimulants crop protection biotechnology research biofungicides bioherbicides bioinsecticides microbial solutions sustainable agriculture natural alternatives chemical pesticides synthetic fertilizers environmental impact r&d platform high-throughput pipeline apexbio microbial diversity plant health yield enhancement environmentally friendly integrated pest management seed treatments foliar applications nutrient use efficiency biological products sustainability ecosystem services biodiversity soil health field trials product development climate change agriculture technology food security research-driven api automated phenotyping data analysis microorganism culturing regulatory compliance certified b corporation esg impact ecovadis sustainability goals sustainable crop solutions agro-biotech plant biotechnology microbial strains product pipeline application types agricultural innovation environmental services renewables & environment data analytics

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Isabel Vercauteren in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Aphea.Bio.

Isabel Vercauteren's Position in the MessageCEO Database

• •Isabel Vercauteren is 1 of 1 verified executive contact we track at Aphea.Bio.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •884 verified executive contacts in Flanders are in the database.
• •12 verified contacts work at research companies in the 81.0 employee range (same size as Aphea.Bio).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.

How do I reach Isabel Vercauteren directly?

Isabel Vercauteren's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Aphea.Bio. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Isabel Vercauteren work for?

Isabel Vercauteren is CEO at Aphea.Bio, a company in the research sector with 81.0 employees. The company is based in Ghent, Flanders.

Can I pitch or sell to Isabel Vercauteren?

As CEO at Aphea.Bio, Isabel Vercauteren is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Isabel Vercauteren directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Isabel Vercauteren in?

Isabel Vercauteren works in the research industry as CEO at Aphea.Bio. MessageCEO provides verified contact information for executives across all major industries.

Is Isabel Vercauteren's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Isabel Vercauteren's profile is kept up-to-date with the latest available information.

Last updated: May 30, 2026